Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
|Articles|March 2, 2022
- Pharmaceutical Technology, March 2022 Issue
- Volume 46
- Issue 3
- Pages: 12
Ultra High Shear Mixer
Author(s)Pharmaceutical Technology Editors
The ROSS X-Series Inline Ultra-High Shear Mixer produces quality dispersions, suspensions, and emulsions in a variety of industries.
The ROSS X-Series Inline Ultra-High Shear Mixer is designed for efficient high- throughput emulsification, dispersion, and homogenization. Available in both sanitary and industrial configurations, this versatile machine produces quality dispersions, suspensions, and emulsions in a variety of industries including food, cosmetic, pharmaceutical, chemical, adhesive, and composites manufacturing.
The Model HSM-409XSHD-125 (pictured right) is a clean-in-place- capable sanitary mixer featuring a type 316 stainless-steel mixing chamber, a 150-psig jacket for cooling and heating up to 250 °F, and an X-5 Series 9” diameter AL6XN stainless-steel rotor/stator that operates up to 5700 rpm (13,430 ft/min tip speed).
The X-Series mix head is a patented design made up of concentric rows of intermeshing teeth—product enters at the middle of the stator and travels outward through the radial channels. Every pass through the rotor/stator exposes the product to tremendous shear because of the combination of very tight tolerances and extremely high tip speeds. Compared to traditional colloid mills, the X-Series routinely achieves a higher reduction in droplet or agglomerate size.
Articles in this issue
over 4 years ago
The Shape of Dosage Formsover 4 years ago
Successfully Accelerating Formulation Strategiesover 4 years ago
Process Performance as a Means of Quality Managementover 4 years ago
The State of Phage Therapyover 4 years ago
Troubleshooting Using Predictive Maintenanceover 4 years ago
A New Route to Pharma GDP Compliance and Standardizationover 4 years ago
Empowering Protein Characterizationover 4 years ago
Cold Comfort for Bio/Pharmaover 4 years ago
Selecting and Optimizing the Right Manufacturing Partnerover 4 years ago
Standing in SolidarityRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5